Postoperative Residual Curarization Clinical Trial
Official title:
Epidemiologic Study on Short and Long-Term Effects of Anesthesia With Muscle Relaxants (Epidemiologische Untersuchung Kurz- Und längerfristiger Auswirkungen Der Anästhesie Mit Muskelrelaxanzien)
This Germany-wide, multi-center, epidemiologic study is designed to evaluate the incidence of post-operative/anesthesia effects of muscle relaxants (i.e. post-operative residual curarization: PORC) and their effect on patient outcome. Aside from biometric data, type of operation, use of muscle relaxants and neuromuscular monitoring, all patients will be clinically evaluated after their operation in the post-anesthesia care unit. To look at long-term effects, patients will be followed-up 28 days after their operation/anesthesia regarding post-operative/anesthesia morbidity and mortality.
Muscle relaxants are integral part of modern anesthesia. They optimize intubating
conditions, reduce laryngeal trauma and improve operating conditions. Drawback is a possible
pharmacological (muscle relaxing) effect of these drugs beyond the end of the operation
(i.e. post-operative residual curarization: PORC). PORC is a relevant complication after
general anesthesia. Reportedly about 30% of all patients who received muscle relaxants show
signs of PORC when arriving in the post-anesthesia care unit. PORC comprises the risk of
impaired post-operative fine motor and coordinative skills with a possible impairment of
swallowing pharyngeal secretions with an increased risk of aspiration after extubation.
Possible deleterious effects of this could be pneumonia, bronchitis, myocardial infarction,
cardiac insufficiency, stoke or re-operation. In a pilot study we were able to identify
clinical assessment criteria to assess patients' risk for aspiration, which are now part of
the post-anesthesia evaluation of every patient.
Unfortunately there is a major pitfall arising from the inability to clearly identify PORC.
Although objective neuromuscular monitoring is the golden standard to measure neuromuscular
transmission during anesthesia, clinical signs have been used to identify muscle weakness
postoperatively. One reason for this practice is the varying action of muscle relaxants at
different muscle groups demonstrating neuromuscular monitoring to be insufficiently
sensitive to detect PORC symptoms at the pharyngeal muscles. This situation may lead to a
seldom use of neuromuscular monitoring devices and may add to a decreasing use of muscle
relaxants in clinical anesthesia.
In this Germany-wide, multi-center, epidemiologic study we would like to evaluate if the use
of muscle relaxants, or signs of their prolonged effect beyond the end of the
operation/anesthesia (PORC), affect the further in-hospital stay and post-operative
morbidity and mortality. The sampling in 8 German hospitals should determine the number of
patients with clinically relevant signs of muscle weakness at the time of arrival in the
post-anesthesia care unit. Therefore a data entry form has been developed by the principal
and sub-investigators of the 8 participating study hospitals. This data entry form enables
the staff in charge of the post-anesthesia care unit to acquire and to document residual
neuromuscular blockades. The sampling will be done in the 8 participating hospitals on 21
randomized working days over a period of 24 hours. To identify the potential risk factors
for postoperative residual curarization, the known predictors for neuromuscular rest
blockades are recorded as well. Known predictors are for example: type and amount of muscle
relaxant, duration of operation and anesthesia, surgical procedure, patients' age,
anesthesia-technique, antagonization of muscle relaxant or neuromuscular monitoring.
Further, the patients' progress in the post-anesthesia care unit is documented.
The 28 day outcome of patients is followed up with a second data entry form which includes
health-economical aspects. Reported are complications, duration of intensive care unit and
hospital stay, as well as remaining health damages at the time of discharge. To estimate the
significance of PORC, data of patients with PORC is compared to data of patients without
PORC. These patients are recruited during the first data collection period in the
post-anesthesia care unit. The control for any patient with PORC is the next one arriving in
the post-anesthesia care unit without PORC.
;
Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05003024 -
Comparison of Train of Four, Tetanus 50 and 100 Hz Recovery After Rocuronium Block Reversed by Sugammadex
|
N/A | |
Completed |
NCT03291184 -
Postoperative Residual Paralysis After Cardiac Surgery
|
N/A | |
Completed |
NCT03804346 -
Infantile - Postoperative Residual Curarization - Study
|
||
Completed |
NCT05066035 -
Residual Paralysis and Reversal With Routine Neostigmine Versus Half-dose Sugammadex and Routine Neostigmine
|
Phase 4 | |
Recruiting |
NCT05760560 -
Incidence of Postoperative Residual Neuromuscular Blockade in the Era of Sugammadex
|
||
Completed |
NCT05224648 -
Comparison of Train of Four, Tetanus 50 and 100 Hz Recovery After Rocuronium Block Reversed by Neostigmine
|
N/A | |
Completed |
NCT03665805 -
Postoperative Residual Curarization in 2018
|
||
Completed |
NCT01651572 -
Comparison Between Cisatracurium and Rocuronium in Terms of Recovery of the Muscular Strength in the Postoperative Phase After Surgery and General Anaesthesia
|
Phase 4 | |
Completed |
NCT03219138 -
Algorithm of Muscle Function Tests to Detect Residual Neuromuscular Blockade.
|
N/A | |
Completed |
NCT02697929 -
Sugammadex/Neostigmine and Liver Transplantation
|
N/A | |
Recruiting |
NCT03923556 -
Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade at the End of Kidney Transplantation Surgery
|
Phase 4 | |
Not yet recruiting |
NCT03460509 -
Reversal With Low Doses of Sugammadex in Patients Undergoing Non-cardiac Surgery
|
Phase 4 | |
Recruiting |
NCT05051371 -
Postoperative Residual Curarization in Elderly Patients in Post-anesthesia Care Unit
|